Warning: The NCBI web site requires JavaScript to function. more...
The pharmaceutical death-ride of dihydroartemisinin.
Jansen FH.
Malar J. 2010 Jul 22;9:212.
Related citations
Simple field assays to check quality of current artemisinin-based antimalarial combination formulations.
Ioset JR, Kaur H.
PLoS One. 2009 Sep 30;4(9):e7270.
Artemisinin-based combination therapies (ACTs): best hope for malaria treatment but inaccessible to the needy!
Mutabingwa TK.
Acta Trop. 2005 Sep;95(3):305-15. Review.
The initial pharmaceutical development of an artesunate/amodiaquine oral formulation for the treatment of malaria: a public-private partnership.
Lacaze C, Kauss T, Kiechel JR, Caminiti A, Fawaz F, Terrassin L, Cuart S, Grislain L, Navaratnam V, Ghezzoul B, Gaudin K, White NJ, Olliaro PL, Millet P.
Malar J. 2011 May 23;10:142.
Anti-malarial market and policy surveys in sub-Saharan Africa.
Diap G, Amuasi J, Boakye I, Sevcsik AM, Pecoul B.
Malar J. 2010 Apr 23;9 Suppl 1:S1.
Medicines for Malaria Venture: sustaining antimalarial drug development.
Bathurst I, Hentschel C.
Trends Parasitol. 2006 Jul;22(7):301-7. Epub 2006 Jun 6. Review.
[Combined antimalarial therapy using artemisinin].
Majori G.
Parassitologia. 2004 Jun;46(1-2):85-7. Review. Italian.
Quality of anti-malarial drugs provided by public and private healthcare providers in south-east Nigeria.
Onwujekwe O, Kaur H, Dike N, Shu E, Uzochukwu B, Hanson K, Okoye V, Okonkwo P.
Malar J. 2009 Feb 10;8:22.
Role and functions of the International Pharmacopoeia.
Wieniawski W.
Ann Ist Super Sanita. 1975;11(3-4):204-10.
Physical and chemical stability of expired fixed dose combination artemether-lumefantrine in uncontrolled tropical conditions.
Bate R, Tren R, Hess K, Attaran A.
Malar J. 2009 Feb 25;8:33.
Artemisinin--an innovative cornerstone for anti-malaria therapy.
Kuhn T, Wang Y.
Prog Drug Res. 2008;66:383, 385-422. Review.
Improvements in access to malaria treatment in Tanzania after switch to artemisinin combination therapy and the introduction of accredited drug dispensing outlets - a provider perspective.
Alba S, Hetzel MW, Goodman C, Dillip A, Liana J, Mshinda H, Lengeler C.
Malar J. 2010 Jun 15;9:164.
Artemisinin-based combination therapy for treating uncomplicated malaria.
Sinclair D, Zani B, Donegan S, Olliaro P, Garner P.
Cochrane Database Syst Rev. 2009 Jul 8;(3):CD007483. Review.
Efficacy and effectiveness of dihydroartemisinin-piperaquine versus artesunate-mefloquine in falciparum malaria: an open-label randomised comparison.
Smithuis F, Kyaw MK, Phe O, Aye KZ, Htet L, Barends M, Lindegardh N, Singtoroj T, Ashley E, Lwin S, Stepniewska K, White NJ.
Lancet. 2006 Jun 24;367(9528):2075-85.
Artemisinin-based combination therapies for uncomplicated malaria.
Davis TM, Karunajeewa HA, Ilett KF.
Med J Aust. 2005 Feb 21;182(4):181-5. Review.
WHO Expert Committee on Specifications for Pharmaceutical Preparations.
World Health Organization.
World Health Organ Tech Rep Ser. 2009;(953):1-161.
From artemisinin to new artemisinin antimalarials: biosynthesis, extraction, old and new derivatives, stereochemistry and medicinal chemistry requirements.
Haynes RK.
Curr Top Med Chem. 2006;6(5):509-37. Review.
Dihydroartemisinin-piperaquine against multidrug-resistant Plasmodium falciparum malaria in Vietnam: randomised clinical trial.
Tran TH, Dolecek C, Pham PM, Nguyen TD, Nguyen TT, Le HT, Dong TH, Tran TT, Stepniewska K, White NJ, Farrar J.
Lancet. 2004 Jan 3;363(9402):18-22.
WHO Expert Committee on specifications for pharmaceutical preparations.
[No authors listed]
World Health Organ Tech Rep Ser. 1996;863:1-194. Review.
The therapeutic potential of semi-synthetic artemisinin and synthetic endoperoxide antimalarial agents.
O'Neill PM.
Expert Opin Investig Drugs. 2005 Sep;14(9):1117-28. Review.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on